---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-000174"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2025-01-07T23:59:59+00:00"
generated_at: "2026-05-28T08:45:41.683583+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision appoints Philip Anderson as CFO, grants 500K stock options

## Summary
- Philip Anderson appointed CFO effective Jan 6, 2025, replacing interim CFO Margrit Thomassen who becomes Controller.
- Compensation: $200k base salary, discretionary bonus, and option grant of 500,000 shares at $0.53, vesting monthly over 3 years.
- Anderson previously CFO at Heritage Distilling, Crown Electrokinetics, Kubient; retired from Nov 2022 to Dec 2024.
- Stock options issued under Section 4(a)(2) as inducement to accept employment; no family or discloseable relationships.

## SEC filing metadata
- accession: 0001654954-25-000174
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2025-01-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495425000174/0001654954-25-000174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495425000174/catheter_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-000174
- JSON: https://secwatch.observer/filing/0001654954-25-000174.json
- Plain text: https://secwatch.observer/filing/0001654954-25-000174.txt

## Key facts
- Executive change
  Philip Anderson was appointed as Chief Financial Officer at Catheter Precision, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On January 4, 2025, the Board of Directors of Catheter Precision, Inc. (the “Company”) appointed Philip Anderson as Chief Financial Officer of the Company, effective January 6, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495425000174/0001654954-25-000174-index.htm
- Executive change
  Margrit Thomassen changed role as Interim Chief Financial Officer at Catheter Precision, Inc..
  - Action: ceased serving
  - Role: Interim Chief Financial Officer
  source text: Ms. Margrit Thomassen, the Company’s previous Interim Chief Financial Officer, ceased serving in that capacity on January 6, 2025 and will continue in the role of Company Controller.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495425000174/0001654954-25-000174-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.